FI931794A - Monokvaternaera 2,16-bispiperidinylandrostanderivat - Google Patents

Monokvaternaera 2,16-bispiperidinylandrostanderivat Download PDF

Info

Publication number
FI931794A
FI931794A FI931794A FI931794A FI931794A FI 931794 A FI931794 A FI 931794A FI 931794 A FI931794 A FI 931794A FI 931794 A FI931794 A FI 931794A FI 931794 A FI931794 A FI 931794A
Authority
FI
Finland
Prior art keywords
monoquaternaera
bispiperidinylandrostanderivat
pharmaceutically acceptable
bispiperidinylandrostane
monoquaternary
Prior art date
Application number
FI931794A
Other languages
English (en)
Other versions
FI111644B (fi
FI931794A0 (fi
Inventor
Thomas Sleigh
Ian Craig Carlyle
Alan William Muir
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI931794A0 publication Critical patent/FI931794A0/fi
Publication of FI931794A publication Critical patent/FI931794A/fi
Application granted granted Critical
Publication of FI111644B publication Critical patent/FI111644B/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J43/00Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J43/003Normal steroids having a nitrogen-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Fats And Perfumes (AREA)
FI931794A 1992-04-22 1993-04-21 Menetelmä terapeuttisesti käyttökelpoisten monokvaternaaristen 2,16-bispiperidinyyliandrostaanijohdannaisten valmistamiseksi FI111644B (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP92303612 1992-04-22
EP92303612 1992-04-22

Publications (3)

Publication Number Publication Date
FI931794A0 FI931794A0 (fi) 1993-04-21
FI931794A true FI931794A (fi) 1993-10-23
FI111644B FI111644B (fi) 2003-08-29

Family

ID=8211340

Family Applications (1)

Application Number Title Priority Date Filing Date
FI931794A FI111644B (fi) 1992-04-22 1993-04-21 Menetelmä terapeuttisesti käyttökelpoisten monokvaternaaristen 2,16-bispiperidinyyliandrostaanijohdannaisten valmistamiseksi

Country Status (17)

Country Link
US (1) US5418226A (fi)
EP (1) EP0571012B1 (fi)
JP (1) JP3344764B2 (fi)
KR (1) KR100281296B1 (fi)
AT (1) ATE145918T1 (fi)
AU (1) AU662277B2 (fi)
CA (1) CA2094457C (fi)
CZ (1) CZ286728B6 (fi)
DE (1) DE69306303T2 (fi)
DK (1) DK0571012T3 (fi)
ES (1) ES2097435T3 (fi)
FI (1) FI111644B (fi)
GR (1) GR3022316T3 (fi)
HK (1) HK1001061A1 (fi)
HU (2) HUT64970A (fi)
MX (1) MX9302303A (fi)
NO (1) NO301931B1 (fi)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9302455D0 (en) * 1993-02-08 1993-03-24 Lab Inpharm N V Process for preparing a pharmaceutical preparation having neuromuscular blocking activity
IT1277700B1 (it) * 1995-12-22 1997-11-11 Poli Ind Chimica Spa Processo di preparazione di 2-beta, 16-beta-diamino 3-alfa, 17-beta- diacilossi 5-alfaandrostani, bloccanti neuromuscolari a struttura
AU1874499A (en) * 1997-11-27 1999-06-16 Akzo Nobel N.V. A pharmaceutical formulation of monoquaternary 2,16-bispiperidinylandrostane forintramuscular administration
HU0402017D0 (en) * 2004-10-07 2004-12-28 Richter Gedeon Vegyeszet Environment-friend process for the synthesis of quaternary ammonio-steroids
DK3017817T3 (da) * 2013-07-01 2020-06-08 Maruishi Pharma Rocuronium præparat med forbedret lindring af vaskulær smerte, metode til fremstilling af samme og metode til at undertrykke og lindre vaskulær smerte ved brug af samme

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1138605A (en) * 1965-02-19 1969-01-01 Organon Labor Ltd Improvements in or relating to new 2-ß,16-ß-diamino-androstanes
DE2962627D1 (en) * 1978-09-05 1982-06-09 Akzo Nv Acid addition salts of 16-beta-monoquaternary ammonium derivatives of 2-beta, 16-beta-bis-piperidino-androstanes and pharmaceutical preparations containing same
IE50675B1 (en) * 1979-12-12 1986-06-11 Akzo Nv Bis-and mono-quaternary ammonium derivatives of 2beta,16beta-dipiperidino-5alpha-androstanes,processes for their preparation and pharmaceutical preparations
US4337386A (en) * 1980-01-21 1982-06-29 Caterpillar Tractor Co. Welder control

Also Published As

Publication number Publication date
MX9302303A (es) 1994-03-31
ATE145918T1 (de) 1996-12-15
JPH07267984A (ja) 1995-10-17
DK0571012T3 (da) 1997-05-12
NO931466L (no) 1993-10-25
US5418226A (en) 1995-05-23
CA2094457C (en) 2003-12-09
GR3022316T3 (en) 1997-04-30
KR100281296B1 (ko) 2001-03-02
HU211859A9 (en) 1995-12-28
HU9301173D0 (en) 1993-07-28
CA2094457A1 (en) 1993-10-23
HK1001061A1 (en) 1998-05-22
CZ286728B6 (en) 2000-06-14
DE69306303D1 (de) 1997-01-16
KR930021653A (ko) 1993-11-22
AU662277B2 (en) 1995-08-24
HUT64970A (en) 1994-03-28
CZ68093A3 (en) 1994-01-19
AU3703093A (en) 1993-10-28
EP0571012A2 (en) 1993-11-24
NO931466D0 (no) 1993-04-21
FI111644B (fi) 2003-08-29
EP0571012B1 (en) 1996-12-04
NO301931B1 (no) 1997-12-29
DE69306303T2 (de) 1997-04-17
JP3344764B2 (ja) 2002-11-18
FI931794A0 (fi) 1993-04-21
EP0571012A3 (en) 1995-04-12
ES2097435T3 (es) 1997-04-01

Similar Documents

Publication Publication Date Title
NO2006018I2 (no) Entekavir
AU667920B2 (en) New piperidine derivatives of benzimidazole
KR0156747B1 (en) Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis-b
IL96882A0 (en) Uracil derivatives and pesticides containing the same as active ingredient
GR3021777T3 (en) A pharmaceutical solution comprising derivatives of FK506
IL90271A0 (en) Antiviral drug
DE69505470D1 (de) Pyrrolocarbazol
ATE100459T1 (de) Antifungale antibiotika.
DE69306303T2 (de) Monoquaternäre 2,16-Bispiperidinglandrostanderivate
ATE156486T1 (de) Fungizide 3,4-diaryl-(5h)-furan-2-onederivate
ES2093051T3 (es) Purinil- y pirimidil-tetrahidrofuranos.
FI904449A0 (fi) N-azasicyklo/3.3.0/oktanamider av aromatiska syror.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: N.V. ORGANON

Free format text: N.V. ORGANON